Nukkleus (NASDAQ:DFNS) Announces Earnings Results, Misses Estimates By $177.61 EPS

Nukkleus (NASDAQ:DFNS) posted its quarterly earnings data on Tuesday. The company reported ($180.72) EPS for the quarter, missing the consensus estimate of ($3.11) by ($177.61), reports.

Nukkleus Stock Down 12.2%

Nukkleus stock opened at $27.20 on Wednesday. Nukkleus has a 12 month low of $3.70 and a 12 month high of $1,948.75. The stock has a fifty day simple moving average of $25.46 and a two-hundred day simple moving average of $95.01. The company has a current ratio of 0.25, a quick ratio of 0.21 and a debt-to-equity ratio of 0.07. The firm has a market cap of $20.67 million, a price-to-earnings ratio of -0.07 and a beta of -5.80.

Institutional Investors Weigh In On Nukkleus

Large investors have recently bought and sold shares of the business. Geode Capital Management LLC lifted its stake in Nukkleus by 193.7% during the 4th quarter. Geode Capital Management LLC now owns 124,714 shares of the company’s stock valued at $503,000 after acquiring an additional 82,252 shares during the period. UBS Group AG raised its holdings in shares of Nukkleus by 23.3% during the third quarter. UBS Group AG now owns 80,512 shares of the company’s stock valued at $564,000 after purchasing an additional 15,223 shares during the last quarter. LPL Financial LLC bought a new position in Nukkleus during the fourth quarter valued at approximately $120,000. Engineers Gate Manager LP bought a new position in Nukkleus during the fourth quarter valued at approximately $96,000. Finally, State Street Corp boosted its holdings in Nukkleus by 70.7% in the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after purchasing an additional 7,400 shares during the last quarter. 12.47% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on DFNS shares. Noble Financial raised Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. Weiss Ratings downgraded Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a report on Monday, July 20th. Finally, Wall Street Zen cut Nukkleus from a “sell” rating to a “strong sell” rating in a research note on Saturday. One equities research analyst has rated the stock with a Strong Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

Nukkleus Company Profile

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.